Literature DB >> 1848663

Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.

C Bartholomew1, J N Ihle.   

Abstract

The inappropriate production of the Evi-1 zinc finger protein occurs in retrovirus-induced murine myeloid leukemias and human acute myelogenous leukemias. In murine leukemias, expression of the Evi-1 gene is associated with retroviral insertions either in the Evi-1 locus, which is immediately 5' of the coding region of the gene, or in the genetically linked Cb-1/fim-3 locus. In these studies, we demonstrate by chromosomal walking and pulse field electrophoresis that the Cb-1/fim-3 locus is located 90 kb 5' of the Evi-1 locus. Primary structure analysis of Evi-1 cDNA clones from a Cb-1/fim-3 rearranged cell line (DA-3) demonstrates that transcription initiates 5' of the Evi-1 locus and that the first noncoding exon of the gene is 681 bp larger than previously defined. S1 nuclease protection studies reveal multiple transcription initiation sites within this region. Comparable transcriptional initiation sites were identified in RNA from kidney and ovary, in which the gene is normally expressed, suggesting that retroviral insertions in the Cb-1/fim-3 locus activate transcription from the normal promoter. In one myeloid cell line (DA-3), a single long terminal repeat (LTR) is present in the Cb-1/fim-3 locus. No stable transcripts were detectable from this LTR. In cells with retroviral insertions in the Cb-1/fim-3 locus, one allele of the Evi-1 locus becomes hypermethylated in the 5' region of the gene. Together, these results are most consistent with an LTR-mediated, long-range cis activation of Evi-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848663      PMCID: PMC359852          DOI: 10.1128/mcb.11.4.1820-1828.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.

Authors:  P J Mitchell; C Wang; R Tjian
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

2.  Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias.

Authors:  D Bordereaux; S Fichelson; B Sola; P E Tambourin; S Gisselbrecht
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity.

Authors:  D Jähner; R Jaenisch
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

4.  Interaction between Kb and Q4 gene sequences generates the Kbm6 mutation.

Authors:  J Geliebter; R A Zeff; D H Schulze; L R Pease; E H Weiss; A L Mellor; R A Flavell; S G Nathenson
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

5.  Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc.

Authors:  B Henglein; H Synovzik; P Groitl; G W Bornkamm; P Hartl; M Lipp
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  A large inverted duplication allows homologous recombination between chromosomes heterozygous for the proximal t complex inversion.

Authors:  B G Herrmann; D P Barlow; H Lehrach
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

Review 7.  Molecular basis of human B cell neoplasia.

Authors:  C M Croce; P C Nowell
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

8.  Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster.

Authors:  S M Gasser; U K Laemmli
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

9.  Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines.

Authors:  K Morishita; D S Parker; M L Mucenski; N A Jenkins; N G Copeland; J N Ihle
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

10.  Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene.

Authors:  C Bartholomew; K Morishita; D Askew; A Buchberg; N A Jenkins; N G Copeland; J N Ihle
Journal:  Oncogene       Date:  1989-05       Impact factor: 9.867

View more
  24 in total

1.  Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

Authors:  Kerstin Schwarzwaelder; Steven J Howe; Manfred Schmidt; Martijn H Brugman; Annette Deichmann; Hanno Glimm; Sonja Schmidt; Claudia Prinz; Manuela Wissler; Douglas J S King; Fang Zhang; Kathryn L Parsley; Kimberly C Gilmour; Joanna Sinclair; Jinhua Bayford; Rachel Peraj; Karin Pike-Overzet; Frank J T Staal; Dick de Ridder; Christine Kinnon; Ulrich Abel; Gerard Wagemaker; H Bobby Gaspar; Adrian J Thrasher; Christof von Kalle
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

3.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Authors:  K Morishita; E Parganas; C L William; M H Whittaker; H Drabkin; J Oval; R Taetle; M B Valentine; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.

Authors:  S Fears; C Mathieu; N Zeleznik-Le; S Huang; J D Rowley; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.

Authors:  B L Kreider; S H Orkin; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

6.  Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.

Authors:  D C Foster; C A Sprecher; F J Grant; J M Kramer; J L Kuijper; R D Holly; T E Whitmore; M D Heipel; L A Bell; A F Ching
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.

Authors:  R Delwel; T Funabiki; B L Kreider; K Morishita; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.

Authors:  G Nucifora; C R Begy; H Kobayashi; D Roulston; D Claxton; J Pedersen-Bjergaard; E Parganas; J N Ihle; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.

Authors:  K Morishita; E Parganas; T Matsugi; J N Ihle
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

10.  A combination of transposable elements and magnetic cell sorting provides a very efficient transgenesis system for chicken primary erythroid progenitors.

Authors:  Camila Mejia-Pous; José Viñuelas; Claudine Faure; Joanna Koszela; Koichi Kawakami; Yoshiko Takahashi; Olivier Gandrillon
Journal:  BMC Biotechnol       Date:  2009-09-18       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.